Flocculant Functionalized Separation Media for Antibody Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for purifying biological molecules, such as antibodies, face challenges in effectively separating monomers from aggregates due to limitations in selectivity and operational ranges, particularly in varying pH and conductivity conditions, leading to incomplete purification and potential contamination.
Innovation Solution
Development of a separation medium with flocculant ligands covalently attached to a base surface, which selectively binds impurities like aggregates, allowing for efficient separation of monomers from aggregates across a wide range of pH and conductivity, using cationic, anionic, and non-ionic flocculant ligands immobilized on various surfaces.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional separation media are used, then purification can be performed, but selectivity for separating monomers from aggregates is insufficient and operational range is limited
Solution Approach 1:
The patent employs parameter changes by utilizing flocculant ligands with varying charge densities and molecular weights that respond differently to changes in pH and ionic strength. This allows the separation media to maintain high selectivity across a broad operational range, as the flocculant properties can be tuned to optimize binding under different conditions while preserving monomer-aggregate separation capability
Solution Approach 2:
The invention creates composite separation media by combining flocculant ligands (such as polyethyleneimine, chitosan, or alginate) with solid support matrices. This composite structure integrates the selective binding capability of natural flocculants with the mechanical stability and surface area of engineered supports, achieving both high purification selectivity and broad operational versatility simultaneously
2Manufacturing precision
If conventional purification methods are used, then some purification is achieved, but incomplete purification occurs leading to contamination
Solution Approach 1:
The patent converts the harmful aggregation phenomenon into a beneficial separation mechanism. By using flocculant ligands that specifically bind to aggregated forms through hydrophobic interactions and charge effects, the method transforms aggregates from unwanted contaminants into selectively bound species that can be easily removed, achieving complete purification while eliminating contamination risks
Solution Approach 2:
The flocculant ligand acts as an intermediary between the separation media and the impurities. These ligands mediate the interaction by providing specific binding sites that recognize and capture aggregated species and host cell proteins, enabling complete removal of contaminants while preserving the target monomeric protein throughout the purification process
3Manufacturing precision
If high selectivity is achieved through specific binding, then purification quality improves, but binding capacity and recovery may be compromised
Solution Approach 1:
The patent applies segmentation by dividing the binding function across multiple flocculant ligand types with different specificities. Some ligands are optimized for binding aggregates while others maintain affinity for monomers, allowing the system to achieve high purification quality through selective binding while maintaining overall binding capacity through the combined effect of multiple ligand segments
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The immobilized flocculant separation media demonstrate enhanced selectivity and purity, achieving >90% monomer purity and >85% recovery with improved operational windows, outperforming commercial products by effectively removing high and low molecular weight species and maintaining target molecule stability.
Implementation Method 1
the immobilized flocculant separation media generated therein, dramatically improved the removal of impurities, for e.g., high molecular weight and low molecular weight species (including antibody aggregates) due to their selective binding of impurities
Data Source
AI summary
Provided herein are compositions, methods and uses that relate to or result from providing separation media having at least one flocculant ligand covalently attached to a base surface or support, and the separation and/or purification of biological molecules using the separation media of the present disclosure. Certain embodiments provide separation media which under certain modes of operation, enhance the separation of the molecule of interest from impurities.